The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia

Journal of Human Genetics

Volumn 45, Issue 3, 2000, Pages 138-141

  Yamada, Naoki ^a   Arinami, Tadao ^a   Yamakawa Kobayashi, Kimiko ^a   Watanabe, Hideki ^a   Sohda, Satoshi ^a   Hamada, Hiromi ^a   Kubo, Takeshi ^a   Hamaguchi, Hideo ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Gene; Plasminogen activator inhibitor type 1; Polymorphism; Preeclampsia

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREECLAMPSIA;

EID: 0034029801     PISSN: 14345161     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100380050200     Document Type: Article

References (23)

1. American College of Obstetricians and Gynecologists (1990) National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy [see comments]. Am J Obstet Gynecol 163:1691-1712
2. Bosnia PJ, van den Berg EA, Kooistra T, Siemieniak DR, Slightom JL (1988) Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J Biol Chem 263:9129-9141
3. Burzotta F, Di Castelnuovo A, Amore C, D'Orazio A, Di Bitondo R, Donati MB, lacoviello L (1998) 4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: a model of gene-environment interaction. Thromb Haemost 79:354-358
4. Caron C, Goudemand J, Marey A, Beague D, Ducroux G, Drouvin F (1991) Are haemostatic and fibrinolytic parameters predictors of preeclampsia in pregnancy-associated hypertension? Thromb Haemost 66:410-414
5. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM (1993) The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem 268:10739-10745
6. de Boer K, Lecander I, ten Cate JW, Bonn JJ, Treffers PE (1988) Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol 158:518-522
7. Dekker GA, Sibai BM (1998) Etiology and pathogenesis of preeclampsia - current concepts [Review]. Am J Obstet Gynecol 179:1359-1375
8. Dizon-Townson DS, Nelson LM, Easton K, Ward K (1996) The factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 175:902-905
9. Eriksson P, Kallin B, van 't Hooft FM, Bavenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Nat Acad Sci USA 92:1851-1855
10. Estelles A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR (1989) Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 74:1332-1338
11. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espna F, Loskutoff DJ, Schleef RR (1994) Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84:143-150
12. Follo M, Ginsburg D (1989) Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1. Gene 84:447-453
13. Gilabert J, Estelles A, Aznar J, Espana F, Andres C, Santos T, Valles J (1990) Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia. Thromb Haemost 63:361-366
14. Klinger KW, Winqvist R, Riccio A, Andreasen PA, Sartorio R, Nielsen LS, Stuart N, Stanislovitis P, Watkins P, Douglas R, Grzeschik KH, Alitaro K, Blasi, Dano K (1987) Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Nat Acad Sci USA 84:8548-8552
15. Mannucci PM, Mari D, Merati G, Peyvandi F, Tagliabue L, Sacchi E, Taioli E, Sansoni P, Bertolini S, Franceschi C (1997) Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vasc Biol 17:755-759
16. Mansfield MW, Stickland MH, Grant PJ (1995) Plasminogen activator inhibitor-1 (PAI-1) promoter polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemost 74:1032-1034
17. Margaglione M, Grandone E, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, d'Addedda M, Di Minno G (1997) An alternative method for PAI-1 promoter polymorphism (4G/5G) typing (letter). Thromb Haemost 77:605-606
18. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ (1997) Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vase Biol 17:33-37
19. Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, van Zonneveld AJ, van Mourik JA (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J 5:2539-2544
20. Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B (1993) Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol 100:370-374
21. Sohda S, Arinami T, Hamada H, Yamada N, Hamaguchi H, Kubo T (1997) Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J Med Genet 34:525-526
22. Wiman B, Csemiczky G, Marsk L, Robbe H (1984) The fast inhibitor of tissue plasminogen activator in plasma during pregnancy. Thromb Haemost 52:124-126
23. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney AM, Cambien F (1995) The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost 74:837-841